Pomegranate Health
Welcome to Pomegranate Health — a podcast about the culture of medicine.
Pomegranate Health is celebrating 10 Years of Conversations. To get a guided tour of the back-catalogue and how the podcast addresses all the themes of professional practice take a listen to Episode 132 and Episode 125.
Pomegranate Health is a podcast about the culture of medicine. You'll hear insights from clinicians, researchers, and advocates as they tackle important questions — like how to make difficult clinical and ethical decisions without being influenced by bias, how to communicate better with patients and colleagues, and how to provide healthcare that’s both efficient and fair.
If you're a Fellow of the RACP, time spent listening can be counted toward your CPD hours. And if you're a Basic Physician Trainee, the [Case Report] series can help you prepare for your long case clinical exams.
This is also the home of [IMJ On-Air], featuring authors from the Internal Medicine Journal sharing their latest research. Plus, the [Journal Club] episodes give RACP researchers a space to talk through their work published in other academic journals.
We’d love to hear your thoughts — feel free to leave a comment on each episode or send feedback and ideas to podcast@racp.edu.au.
Latest episodes
Ep78: The Advocate’s Journey
The three word mission statement of the RACP is Educate - Advocate – Innovate. In this podcast we hear from physicians who have taken up a cause, and how the College can help amplify the message.
Ep77: Deciding with Children
When can a child be considered to have autonomy to make healthcare decisions for themselves? How should responsibility for difficult decisions be shared between the patients, the parents and clinicians? And is it possible to minimise the moral injury when the wishes of the patient need to be over-ruled?
Ep76: Making Amends- Medical Injury Part 3
In Australia, litigation is the only way for victims to get financial compensation for the medical injury. New Zealand, by contrast, operates a no-fault scheme where the costs of hardship and ongoing care are born by the government for many harms incurred in healthcare.
Ep75: Feeling Guilty- Medical Injury Part 2
Perhaps the greatest barrier to incident disclosure is culture of medicine itself. This podcast explores the guilt that can come about from having caused harm, and the cognitive dissonance this creates in one’s professional identity as a healer.
Ep74: Saying Sorry- Medical Injury Part 1
Medical injury occurs at a rate of about 12 per cent of admissions but is often not disclosed to patients or their families. This podcast explores why practitioners may be fearful of admitting to errors and how victims want the health system to make amends.
Ep73: Communicating a Pandemic
There are many layers of public health interventions that can reduce the rate of transmission of the novel coronavirus but you need you need the community on board to make a significant impact. In this podcast we discuss the challenges and strategies around messaging to the community during a time of such high anxiety.
Ep72: Modelling a Pandemic—Congress 2021
The COVID-19 pandemic has shown how hard it is to take decisions affecting the lives of millions when there is so little evidence to go on. Models of viral spread and interventions to mitigate these have become everyday discussion points, but few people understand how hard these are to put together.
Ep70: Zeroing in on “the renal troponin”
After over a two decades of research, commercial assays now exist that can predict onset of acute kidney injury in at-risk patients. But many questions remains as whether these are specific enough to be useful at point of care, and whether we have the interventions to respond to the information they provide.
Ep69: Gendered Medicine—Funding and Research
It’s been said that the health needs of women are undervalued by our fee-for-service model, down to individual item numbers in the Medicare Benefits Schedule. There’s also evidence that disease predominantly experienced by females receive less research investment. Is this blatant sexism or a symptom of other structural imbalance? And what do we do about it?